Mackay IrChapter 3. The immunological mediation of drug reactions affecting the liver in Farrell GC: Drug-Induced Liver Disease. Edinburgh London: Churchill Livingstone; 1994:69.
2.
Murray MChapter 1. Role of the Liver in Drug Metabolism in Farrell GC: Drug-Induced Liver Disease. Edinburgh London: Churchill Livingstone; 1994:3.
3.
Murray MChapter 1. Role of the Liver in Drug Metabolism in Farrell GC: Drug-Induced Liver Disease. Edinburgh London: Churchill Livingstone; 1994:13.
4.
Nuk G.Pain control and the use of nonsteroidal analgesic anti-inflammatory drugs.British Medical Bulletin. 1990;46 (1): 262-278
5.
Tarazi Em,Harter Jg,Zimmerman Hj.Sulindac-associated hepatic injury: analysis of 91 cases reported to the Food and Drug Administration.Gastroenterology. 1993;104 (2): 569-574
6.
Boelsterli Ua,Zimmerman Hj,Kretz-Rommel A.Idiosyncratic liver toxicity of nonsteroidal anti-inflammatory drugs: molecular mechanisms and pathology.Crit Rev Toxicol. 1995;25 (3): 207-235
7.
Prescott Lf.Liver damage with non-narcotic analgesics.Med Toxicol. 1986;1:44-56
9. (Michael Colley v. Parke Davis & Company et al, No. 96!-530040-NH, State of Michigan in the Circuit Court for the County of Oakland).
10.
Lee Wm..Drug Induce Hepatotoxicity.New Engl J Med. Oct 26, 1995;Vol 233:1118-1127
11.
11.Rapha Group Software, Inc. 1996.
12.
Linden Ch,Rumack Bh..Acetaminophen Overdose.Emergency Medicine Clinics of North America. February 1984;Vol. 2:103-119
13.
Linden Ch,Rumack Bh.Emergency Medicine, A Comprehensive Study Guide. Tintinalli JeKrome RlRuiz E., ed. New York: McGraw-Hill; 1992:
14.
14.ReynoldsJef, ed. Martindale, The Extra Pharmacopoeis, 29th Ed.1989, p. 32.
15.
Prescott Lf,Critchley Jajh,Balali-Mood M,Pentland B..Effects of Microsomal Enzyme Induction on Paracetamol Metabolism in Man.Br. J. Clin Pharmc.. 1981;12:149-153
16.
Minton Na,Henry A,Frankel Rj..Fatal Paracetamol Poisoning in an Epileptic.Human Toxicol. 1988;7:33-34
17.
The Pill Book. 7th EditionSilverman Hm., ed. New York: Bantam Books; 1996:
18.
18.KaplowitzN.Drug Metabolism and Hepatotoxicity, 1992.
19.
Wallace Rj Jr.,Brown Ba,Griffith De..Drug intolerance to high-dose clarithromycin among elderly patients.Diagn Microbiol Infect Dis. 1993;16 (3): 215-221
22.HussarDa.They may call it an “express,” but it is on the wrong track (Call for Rezulin Market Withdrawal). Editorial. Pharmacy Today, October 1999. American Pharmaceutical Association.
23.
Crosby Wh..Hemochromatosis, The Missed Diagnosis.Arch Intern Med. June 1986;Vol 146:1209-1210
24.
24.FauciSBraunwaldEIsselbacherKj, et al: Harrison's Principles of Internal Medicine, 14th Edition, Harrison's Online (http://222.harrisononline.com) last modified: August 18, 1998, copyright the McGraw Hill Companies, New York.
25.
Edwards Cg,Skolnick Mh,Kushner Jp..Coincidental Nontransfusional Iron Overload and Thalassemia Minor: Association with HLA-Linked Hemochromatosis.Blood. 1981;Vol. 58:844-848
26.
Lewis M,Lee Gr,Haut A.The association of hemochromatosis with thalassemia minor.Ann Intern Med. 1965;63:122
27.
Finch Ca,Monsen Er..Iron nutrition and fortification of food with iron.JAMA. 1972;219:1462-1465
28.
Olsson Ks,Heedman Pa,Staugard F..Preclinical Hemochromatosis in a Population on a High Iron Fortified Diet.JAMA. 1978 1999––2000;vol 239:
29.
It's Your Choice. New York, NY: Cooley's Anemia Foundation, Inc.; 10/92.
30.
Mendell E.Earl Mindell's New and Revised Vitamin Bible. New York: Warner Books; 1985:91-93.
31.
Natow Ab,Heslin J.The Iron Counter. New York: Pocket Books; 1993:
32.
Grogan Fj.The Pharmacist's Prescription: Your Complete Guide to the Over-the-Counter Remedies That Work Best. New York: Rawson Associates; 1987:291-294.
33.
Bowdler Aj,Heuhns Er..Thalassaemia Minor Complicated by Excessive Iron Storage.Br. J. Haemot. 9:13-24
34.
Wyatt Jp,Mighton Hk,Moragues V..Transfusional siderosis.Amer. J. Path. 1950;26:883
